GGrantIndex
Sort

64,565 grants matching drug discovery

National Emerging Infectious Diseases Laboratories Operations

$12,697,405
Ronald B Corley · Boston University Medical Campus · UC7 · FY2015 · AI

Institutional Clinical and Translational Science Award

$12,549,419
Garret A Fitzgerald · University Of Pennsylvania · UL1 · FY2007 · RR

The Center for Therapeutic Targeting of EWS-oncoproteins

$12,500,000
Kimberly Stegmaier · Dana-Farber Cancer Inst · U54 · FY2018 · CA

Region VI Center for Biodefence and Emerging Infections

$12,477,542
University Of Texas Medical Br Galveston · U54 · FY2005 · AI

Category II: Exploring Neural Network Processors for AI in Science and Engineering

$12,249,999
Amitava Majumdar · University Of California-San Diego · · FY2020 · CSE

Institutional Clinical and Translational Science Award

$12,110,988
Garret A Fitzgerald · University Of Pennsylvania · UL1 · FY2009 · RR

Institutional Clinical and Translational Science Award

$12,048,641
Garret A Fitzgerald · University Of Pennsylvania · UL1 · FY2008 · RR

Institutional Clinical and Translational Science Award

$12,007,471
Garret A Fitzgerald · University Of Pennsylvania · UL1 · FY2010 · RR

Whole Genome Sequencing in Ethnically Diverse Cohorts for the ADSP Follow-Up Study (FUS)

$11,819,206
Margaret A Pericak-Vance · University Of Miami School Of Medicine · U01 · FY2017 · AG

Leadership Group for the Infectious Diseases Clinical Research Consortium (IDCRCLG)

$11,669,860
David S Stephens · Emory University · UM1 · FY2022 · AI

Novel Dopamine D3/D2 Receptor Ligands

$11,662,952
Amy Hauck Newman · National Institute On Drug Abuse · ZIA · FY2023 · DA

Dana-Farber/Harvard Cancer Center

$11,592,798
Laurie H Glimcher · Dana-Farber Cancer Inst · P30 · FY2017 · CA

Johns Hopkins Institute for Clinical and Translational Research

$11,584,805
Daniel Ernest Ford · Johns Hopkins University · UL1 · FY2021 · TR

Region VI Center for Biodefence and Emerging Infections

$11,566,950
University Of Texas Medical Br Galveston · U54 · FY2004 · AI

Limited Competition: National Biocontainment Laboratories (NBLs) Operations Support (UC7 Clinical Trial Not Allowed)

$11,500,000
Gene Garrard Olinger · University Of Texas Med Br Galveston · UC7 · FY2024 · AI

Limited Competition: National Biocontainment Laboratories (NBLs) Operations Support (UC7 Clinical Trial Not Allowed)

$11,500,000
Gene Garrard Olinger · University Of Texas Med Br Galveston · UC7 · FY2025 · AI

Limited Competition: National Biocontainment Laboratories (NBLs) Operations Support (UC7 Clinical Trial Not Allowed)

$11,500,000
Gary Kobinger · University Of Texas Med Br Galveston · UC7 · FY2023 · AI

Limited Competition: National Biocontainment Laboratories (NBLs) Operations Support (UC7 Clinical Trial Not Allowed)

$11,500,000
Gary Kobinger · University Of Texas Med Br Galveston · UC7 · FY2021 · AI

Limited Competition: National Biocontainment Laboratories (NBLs) Operations Support (UC7 Clinical Trial Not Allowed)

$11,500,000
Gary Kobinger · University Of Texas Med Br Galveston · UC7 · FY2022 · AI

Dana-Farber/Harvard Cancer Center

$11,495,112
Laurie H Glimcher · Dana-Farber Cancer Inst · P30 · FY2019 · CA

Dana-Farber/Harvard Cancer Center

$11,475,747
Laurie H Glimcher · Dana-Farber Cancer Inst · P30 · FY2021 · CA

Dana-Farber/Harvard Cancer Center

$11,475,747
Laurie H Glimcher · Dana-Farber Cancer Inst · P30 · FY2020 · CA

DCTD Human Toxicology and Pharmacology

$11,440,830
David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2012 · CA

NSEC for Molecular Function at the Nano/Bio Interface

$11,403,500
Dawn A Bonnell · University Of Pennsylvania · · FY2004 · MPS

Region VI Center for Biodefence and Emerging Infections

$11,399,642
David H Walker · University Of Texas Med Br Galveston · U54 · FY2006 · AI